Evidence map›Paper›PMID 40856424›Full record

ArticleHistopathology2025

Two similar but distinct types of breast acinar cell carcinoma: evidence from histological, immunohistochemical and molecular features.

Mingfang Sun, Lin Fu, Hongjiu Ren, Jian Wang, Xuyong Lin, Qingfu Zhang

Abstract read
In one paragraph

Article in Histopathology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingfang SunDepartment of Pathology, The First Hospital of China Medical University, Shenyang, China.ORCID https://orcid.org/0000-0003-0194-4903
Lin FuDepartment of Pathology, The First Hospital of China Medical University, Shenyang, China.ORCID https://orcid.org/0009-0004-2694-9668
Hongjiu RenDepartment of Pathology, The First Hospital of China Medical University, Shenyang, China.ORCID https://orcid.org/0009-0005-3777-4645
Jian WangDepartment of Pathology, The First Hospital of China Medical University, Shenyang, China.ORCID https://orcid.org/0009-0000-0907-9163
Xuyong LinDepartment of Pathology, The First Hospital of China Medical University, Shenyang, China.ORCID https://orcid.org/0000-0001-6714-0639
Qingfu ZhangDepartment of Pathology, The First Hospital of China Medical University, Shenyang, China.

Funding

This work was supported by the National Nature Science Foundation of China (grant No. 81702269) and Natural Science Foundation of Liaoning Province (grant No. 2022-MS-198).
6 · The paper itself

Abstract

aimsBreast acinar cell carcinoma (AciCC) is a rare breast cancer subtype that exhibits morphological similarities to salivary gland AciCC. However, the molecular profile of breast AciCC differs significantly from that of salivary gland AciCC, suggesting that they may not be related. Whether breast AciCC represents a distinct breast cancer subtype remains controversial. METHODS AND

resultsThis study analysed two groups of breast AciCCs. Using comprehensive morphological, immunohistochemical, fluorescence in situ hybridisation and next-generation sequencing analyses, we elucidated the similarities and differences between these two distinct types of 'breast AciCCs' and their salivary gland counterpart. The first, based on morphological and immunohistochemical features, satisfied the 2019 World Health Organization diagnostic criteria for breast AciCC. Notably, NR4A3, a specific marker for salivary gland AciCC, was not expressed in these cases. We propose designating this tumour type as 'carcinoma with acinar cell differentiation'. In contrast, the second group included a case of AciCC in situ, which demonstrated morphological, immunohistochemical and molecular features identical to those of salivary gland AciCC, including NR4A3 protein overexpression and NR4A3 gene rearrangement. This case was considered a precursor of true salivary gland-type AciCC originating in the breast.

conclusionsThis study provides new insights into breast AciCC nomenclature: the widely recognised AciCC name, 'carcinoma with acinar cell differentiation' might be more appropriate. Although true salivary gland-type AciCC requires additional cases for confirmation, our case has clarified that true salivary gland-type AciCC can indeed exist in the breast.

Indexed as

Breast NeoplasmsCarcinoma, Acinar CellAdultAgedBiomarkers, TumorDNA-Binding ProteinsFemaleHumansImmunohistochemistryMiddle AgedReceptors, SteroidReceptors, Thyroid HormoneSalivary Gland NeoplasmsBiomarkers, TumorDNA-Binding ProteinsNR4A3 protein, humanReceptors, SteroidReceptors, Thyroid Hormoneacinar cell carcinomabreast salivary‐gland type tumourscarcinoma in situnuclear receptor subfamily 4 group A member 3

Identifiers

PMID40856424
PMCPMC12605734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.